(Q34100103)

31 July 2017

1 reference

title

B cells and antibodies in CNS demyelinating disease (English)

1 reference

31 July 2017

1 reference

1

Cross AH

1 reference

31 July 2017

Trotter JL

2

1 reference

PubMed ID

11108928

31 July 2017

Lyons J

series ordinal

3

1 reference

PubMed ID

11108928

31 July 2017

language of work or name

1 reference

1 January 2001

1 reference

Journal of Neuroimmunology

31 July 2017

1 reference

31 July 2017

112

1 reference

31 July 2017

1-14

1 reference

31 July 2017

1-2

1 reference

Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

GAMMA-GLOBULIN AFFINITY FOR NORMAL HUMAN TISSUE OF THE CENTRAL NERVOUS SYSTEM.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: importance depends on the nature of the antigen-antibody interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Multiple sclerosis: cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

CD80 (B7-1) and CD86 (B7-2) expression in multiple sclerosis patients: clinical subtype specific variation in peripheral monocytes and B cells and lack of modulation by high dose methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

A humoral response to oligodendrocyte-specific protein in MS: a potential molecular mimic

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Cells of cerebrospinal fluid of multiple sclerosis patients secrete antibodies to myelin basic protein in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Immunocytochemical localization of the terminal complement complex in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Multiple sclerosis immune complexes: An analysis of component antigens and antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Immunoblot detection of oligoclonal anti-myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Epitope-directed processing of specific antigen by B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Expression of the murine complement regulatory protein crry by glial cells and neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Antibodies to proteolipid apoprotein in chronic relapsing experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Immunoglobulin-containing cells in multiple-sclerosis plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Regulation of B-cell activation and antigen presentation by Fc receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Intact B-cell activity is essential for complete expression of experimental allergic encephalomyelitis in Lewis rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytological study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Late complications of immune deviation therapy in a nonhuman primate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Identification of autoantibodies associated with myelin damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

The involvement of specific anti myelin basic protein antibody-forming cells in multiple sclerosis immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Opsonization of normal myelin by anti-myelin antibodies and normal serum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Experimental allergic encephalomyelitis. Characterization of serum factors causing demyelination and swelling of myelin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Detection of serum antibody against arrestin from patients with acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Binding of complement component Clq to myelin oligodendrocyte glycoprotein: A novel mechanism for regulating CNS inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Anti-glycolipid antibodies and their immune complexes in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

The abnormal function of T cells in chronically anti-mu-treated mice with no mature B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

In vivo demyelinating activity of sera from animals with chronic experimental allergic encephalomyelitis. Antibody nature of the demyelinating factor and the role of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Fc gamma RII on human B cells can mediate enhanced antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Retargeting T cell-mediated inflammation: a new perspective on autoantibody action

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Cells producing antibodies specific for myelin basic protein region 70-89 are predominant in cerebrospinal fluid from patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Oligoclonal IgG in multiple sclerosis and subacute sclerosing panencephalitis brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Oligoclonal IgG bands in plaques from multiple sclerosis brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Anti-myelin antibodies modulate experimental allergic encephalomyelitis in Biozzi ABH mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Kinetics of anaphylatoxin C5a receptor expression during experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Circulating immune complexes in neurologic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: exacerbations and remissions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Restricted use of VH4 germline segments in an acute multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Neuroimmunologic Diseases: Effector Cell Responses and Immunoregulatory Mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

The fine structure of chronically active multiple sclerosis plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Electron microscopy and immunoperoxidase studies of early multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Circulating immune complexes in serum and in cerebrospinal fluid of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Immunoglobulins promote remyelination in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Multiple sclerosis. Cerebrospinal fluid immune complexes that bind C1q

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Induction of anti-myelin antibodies in EAE and their possible role in demyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

The expression of complement regulatory proteins by adult human oligodendrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Intrathecal activation of the complement system and disability in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Intrathecal IgG synthesis and autoantibody-secreting cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Importance of intrathecal synthesis of IgD in multiple sclerosis. A combined clinical, immunologic, and magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

EAE cerebrospinal fluid augments in vitro phagocytosis and metabolism of CNS myelin by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

B cells solicit their own help from T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Humoral immune responses to myelin basic protein, cerebroside and ganglioside in chronic relapsing experimental allergic encephalomyelitis of the guinea pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Anti-endothelial cell antibodies and circulating immune complexes in the sera of patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Opsonization with antimyelin antibody increases the uptake and intracellular metabolism of myelin in inflammatory macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Fc receptors for IgG on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Chronic experimental allergic encephalomyelitis and antibody responses in rabbits immunized with bovine proteolipid apoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Dual implication of 2',3'-cyclic nucleotide 3' phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Immunoglobulin G, A, and M--clonal restriction in multiple sclerosis cerebrospinal fluid and serum--analysis by two-dimensional electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Enhancement of EAE and induction of autoantibodies to T-cell epitopes in mice infected with a recombinant vaccinia virus encoding myelin proteolipid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

A correlation between cerebrospinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

A study of oligoclonal band negative multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900409-4

7 January 2021

10.1016/S0165-5728(00)00409-4

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11108928